{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:02:11Z","timestamp":1791453731564,"version":"4.3.3"},"reference-count":97,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jaci.2020.03.005","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T20:04:42Z","timestamp":1585253082000},"page":"1510-1516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["The role of eosinophils in chronic spontaneous urticaria"],"prefix":"10.1016","volume":"145","author":[{"given":"Sabine","family":"Altrichter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Frischbutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie Shen","family":"Fok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Kolkhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Stahl","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K.","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4121-481X","authenticated-orcid":false,"given":"Marcus","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.03.005_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imr.12638","article-title":"Human eosinophils and mast cells: birds of a feather flock together","volume":"282","author":"Robida","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2020.03.005_bib2","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1073\/pnas.1112268109","article-title":"Mast cells orchestrate type 2 immunity to helminths through regulation of tissue-derived cytokines","volume":"109","author":"Hepworth","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.03.005_bib3","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.pt.2016.05.004","article-title":"Eosinophils in helminth infection: defenders and dupes","volume":"32","author":"Huang","year":"2016","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.jaci.2020.03.005_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9095275","article-title":"Eosinophils from physiology to disease: a comprehensive review","volume":"2018","author":"Ramirez","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jaci.2020.03.005_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fimmu.2014.00061","article-title":"Helminth Allergens, Parasite-specific IgE, and its protective role in human immunity","volume":"5","author":"Fitzsimmons","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/IJGM.S8088","article-title":"Pathophysiology of nasal congestion","volume":"3","author":"Naclerio","year":"2010","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.jaci.2020.03.005_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5415\/apallergy.2011.1.3.157","article-title":"Overview on the pathomechanisms of allergic rhinitis","volume":"1","author":"Pawankar","year":"2011","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.jaci.2020.03.005_bib8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA(2)LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.03.005_bib9","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jaci.2016.08.050","article-title":"Autoimmune chronic spontaneous urticaria: what we know and what we do not know","volume":"139","author":"Kolkhir","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaci.2014.04.036","article-title":"The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria","volume":"135","author":"Chang","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014794","article-title":"IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria?","volume":"6","author":"Altrichter","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2020.03.005_bib12","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jaci.2017.10.035","article-title":"IL-24 is a common and specific autoantigen of IgE in chronic spontaneous urticaria","volume":"142","author":"Schmetzer","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7150\/thno.29902","article-title":"On the lipophilic nature of autoreactive IgE in chronic spontaneous urticaria","volume":"9","author":"Lakin","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jaci.2020.03.005_bib14","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1111\/all.13949","article-title":"Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria (aiCSU): results of the PURIST study","volume":"74","author":"Schoepke","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.03.005_bib15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2222.1991.tb03198.x","article-title":"Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria","volume":"21","author":"Grattan","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2020.03.005_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4168\/aair.2012.4.2.68","article-title":"Eosinophil development, regulation of eosinophil-specific genes, and role of eosinophils in the pathogenesis of asthma","volume":"4","author":"Uhm","year":"2012","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2020.03.005_bib17","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1084\/jem.182.4.1169","article-title":"Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in\u00a0vivo","volume":"182","author":"Collins","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2020.03.005_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1074-7613(00)80294-0","article-title":"IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses","volume":"4","author":"Kopf","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2020.03.005_bib19","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1073\/pnas.261462598","article-title":"The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness","volume":"99","author":"Humbles","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.03.005_bib20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.179.2.751","article-title":"Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine","volume":"179","author":"Dahinden","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2020.03.005_bib21","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1126\/science.3110954","article-title":"Eosinophils cocultured with endothelial cells have increased survival and functional properties","volume":"237","author":"Rothenberg","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.jaci.2020.03.005_bib22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00011-009-0042-6","article-title":"Mast cells and eosinophils: the two key effector cells in allergic inflammation","volume":"58","author":"Minai-Fleminger","year":"2009","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jaci.2020.03.005_bib23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3389\/fimmu.2017.00484","article-title":"Eosinophils in autoimmune diseases","volume":"8","author":"Diny","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fmed.2017.00103","article-title":"Bidirectional mast cell-eosinophil interactions in inflammatory disorders and cancer","volume":"4","author":"Galdiero","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2020.03.005_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/bjd.12991","article-title":"Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin","volume":"171","author":"Kay","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.03.005_bib26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2133.1986.tb04065.x","article-title":"A serological mediator in chronic idiopathic urticaria--a clinical, immunological and histological evaluation","volume":"114","author":"Grattan","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.03.005_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00000372-199602000-00008","article-title":"Free eosinophil granules in\u00a0urticaria: a correlation with the duration of wheals","volume":"18","author":"Toyoda","year":"1996","journal-title":"Am J Dermatol"},{"key":"10.1016\/j.jaci.2020.03.005_bib28","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0091-6749(86)90240-X","article-title":"Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells","volume":"78","author":"Elias","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.iac.2013.09.012","article-title":"Chronic spontaneous urticaria: etiology and pathogenesis","volume":"34","author":"Saini","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2020.03.005_bib30","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1067\/mai.2002.123236","article-title":"TH1\/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction","volume":"109","author":"Ying","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1034\/j.1600-0625.2003.00010.x","article-title":"Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test","volume":"12","author":"Caproni","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2020.03.005_bib32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.alit.2017.06.012","article-title":"Histopathological and clinical evaluation of chronic spontaneous urticaria patients with neutrophilic and non-neutrophilic cutaneous infiltrate","volume":"67","author":"Martins","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2020.03.005_bib33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF01262329","article-title":"Comparative immunoreactivity of the eosinophil constituents MBP and ECP in different types of urticaria","volume":"287","author":"Haas","year":"1995","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaci.2020.03.005_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0190-9622(89)70151-1","article-title":"Evidence for eosinophil degranulation with deposition of granule major basic protein in solar urticaria","volume":"21","author":"Leiferman","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2020.03.005_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0091-6749(87)90015-7","article-title":"Morphologically distinctive forms of cutaneous mast cell degranulation induced by cold and mechanical stimuli: an ultrastructural study","volume":"80","author":"Murphy","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0091-6749(85)90801-2","article-title":"Mediator release in local heat urticaria: protection with combined H1 and H2 antagonists","volume":"76","author":"Irwin","year":"1985","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2133.1986.tb05754.x","article-title":"Cholinergic dermographism","volume":"115","author":"Mayou","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.03.005_bib38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archderm.1988.01670020048016","article-title":"Delayed pressure urticaria histologically resembles cutaneous late-phase reactions","volume":"124","author":"Mekori","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2020.03.005_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1523-1747.ep12538380","article-title":"Localization of eosinophil granule major basic protein in chronic urticaria","volume":"81","author":"Peters","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.03.005_bib40","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/mai.2002.122462","article-title":"Localized heat urticaria associated with mast cell and eosinophil degranulation","volume":"109","author":"Koh","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-2776(08)01003-1","article-title":"Biology of the eosinophil","volume":"101","author":"Blanchard","year":"2009","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib42","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000155748","article-title":"Expression of tissue factor by eosinophils in patients with chronic urticaria","volume":"148","author":"Cugno","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/CRIAI:30:1:013","article-title":"Eosinophils and urticaria","volume":"30","author":"Staumont-Salle","year":"2006","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ni.1984","article-title":"Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells","volume":"12","author":"Islam","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature12526","article-title":"Type 2 innate lymphoid cells control eosinophil homeostasis","volume":"502","author":"Nussbaum","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2020.03.005_bib46","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1006\/cyto.1999.0487","article-title":"Dermal fibroblasts represent a potent major source of human eotaxin: in\u00a0vitro production and cytokine-mediated regulation","volume":"11","author":"Miyamasu","year":"1999","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2020.03.005_bib47","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1084\/jem.20141671","article-title":"IgE-activated basophils regulate eosinophil tissue entry by modulating endothelial function","volume":"212","author":"Cheng","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2020.03.005_bib48","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jaip.2018.11.018","article-title":"Dupilumab as a novel therapy for difficult to treat chronic spontaneous urticaria","volume":"7","author":"Lee","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.03.005_bib49","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.jid.2019.03.1129","article-title":"Eosinophils mediate basophil-dependent allergic skin inflammation in mice","volume":"139","author":"JU","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.03.005_bib50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/WOX.0b013e3181bb965f","article-title":"Eosinophils in chronic urticaria: supporting or leading actors?","volume":"2","author":"Asero","year":"2009","journal-title":"World Allergy Organ J"},{"issue":"Suppl 1","key":"10.1016\/j.jaci.2020.03.005_bib51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000053571","article-title":"Human skin mast cells produce TNF-alpha by substance P","volume":"117","author":"Okayama","year":"1998","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1020235400073","article-title":"Interleukin-3 production by mast cells from human lung","volume":"23","author":"Ishizuka","year":"1999","journal-title":"Inflammation"},{"key":"10.1016\/j.jaci.2020.03.005_bib53","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.4049\/jimmunol.0902447","article-title":"Cutting edge: basophils are transiently recruited into the draining lymph nodes during helminth infection via IL-3, but infection-induced Th2 immunity can develop without basophil lymph node recruitment or IL-3","volume":"184","author":"Kim","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib54","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41419-018-0526-9","article-title":"IL-3 but not monomeric IgE regulates FcepsilonRI levels and cell survival in primary human basophils","volume":"9","author":"Zellweger","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jaci.2020.03.005_bib55","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.pop.2016.07.010","volume":"43","author":"Kovalszki","year":"2016","journal-title":"Eosinophilia. Prim Care"},{"key":"10.1016\/j.jaci.2020.03.005_bib56","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-94-3-352","article-title":"Total absence of eosinophils in a patient with an allergic disorder","volume":"94","author":"Franklin","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2020.03.005_bib57","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1398-9995.1998.tb03901.x","article-title":"Syndromes associated with eosinopenia","volume":"53","author":"Freeman","year":"1998","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.03.005_bib58","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1600-0609.1988.tb00193.x","article-title":"Total absence of eosinophils in a patient with chronic urticaria and vitiligo","volume":"40","author":"Juhlin","year":"1988","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaci.2020.03.005_bib59","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaip.2019.08.025","article-title":"Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity and poor response to treatment","volume":"8","author":"Kolkhir","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.03.005_bib60","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/23744235.2017.1388537","article-title":"Pitfalls in studies of eosinopenia and neutrophil-to-lymphocyte count ratio","volume":"50","author":"Karakonstantis","year":"2018","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.jaci.2020.03.005_bib61","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000477","article-title":"Low eosinophil and low lymphocyte counts and the incidence of 12 cardiovascular diseases: a CALIBER cohort study","volume":"3","author":"Shah","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.jaci.2020.03.005_bib62","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5615109","article-title":"Cutting edge: biomarkers for chronic spontaneous urticaria","volume":"2018","author":"Folci","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaci.2020.03.005_bib63","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000233803","article-title":"Tissue localization of human eosinophil cationic proteins in allergic diseases","volume":"77","author":"Spry","year":"1985","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib64","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2014.05.004","article-title":"Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria","volume":"134","author":"Fujisawa","year":"2014","journal-title":"J Allergy Clin Immun"},{"key":"10.1016\/j.jaci.2020.03.005_bib65","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(77)92440-0","article-title":"A new syndrome characterised by absence of eosinophils and basophils","volume":"1","author":"Juhlin","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2020.03.005_bib66","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1172\/JCI110024","article-title":"Effects of corticosteroids on eosinophil chemotaxis and adherence","volume":"67","author":"Altman","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.03.005_bib67","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/all.12169","article-title":"The consequences of not having eosinophils","volume":"68","author":"Gleich","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.03.005_bib68","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1182\/blood-2005-07-2926","article-title":"The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils","volume":"107","author":"Munitz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.03.005_bib69","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1074\/jbc.275.2.861","article-title":"Siglec-8. A\u00a0novel eosinophil-specific member of the immunoglobulin superfamily","volume":"275","author":"Floyd","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2020.03.005_bib70","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pharmthera.2016.10.010","article-title":"Mast cell and eosinophil surface receptors as targets for anti-allergic therapy","volume":"170","author":"Gangwar","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jaci.2020.03.005_bib71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev.me.44.020193.000505","article-title":"The biology of the eosinophilic leukocyte","volume":"44","author":"Gleich","year":"1993","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaci.2020.03.005_bib72","doi-asserted-by":"crossref","first-page":"17406","DOI":"10.1074\/jbc.R113.546218","article-title":"Eosinophil granule proteins: form and function","volume":"289","author":"Acharya","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2020.03.005_bib73","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2003.08.028","article-title":"Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization","volume":"112","author":"Davis","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib74","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/j.1365-2222.2005.02380.x","article-title":"In chronic idiopathic urticaria autoantibodies against Fc epsilonRII\/CD23 induce histamine release via eosinophil activation","volume":"35","author":"Puccetti","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2020.03.005_bib75","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.alit.2014.07.006","article-title":"Increased thrombin generation potential in patients with chronic spontaneous urticaria","volume":"64","author":"Sakurai","year":"2015","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2020.03.005_bib76","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.4049\/jimmunol.133.6.3282","article-title":"Thrombin-induced degranulation of cultured bone marrow-derived mast cells","volume":"133","author":"Razin","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib77","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2012-02-412080","article-title":"Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway","volume":"120","author":"Krisinger","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.03.005_bib78","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1111\/all.13587","article-title":"Elevated IgE to tissue factor and thyroglobulin are abated by omalizumab in chronic spontaneous urticaria","volume":"73","author":"Cugno","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.03.005_bib79","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/j.1398-9995.2009.02069.x","article-title":"Plasma levels and skin-eosinophil-expression of vascular endothelial growth factor in patients with chronic urticaria","volume":"64","author":"Tedeschi","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.03.005_bib80","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1182\/blood.V97.4.1086","article-title":"Human peripheral blood eosinophils express stem cell factor","volume":"97","author":"Hartman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.03.005_bib81","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/1568010033483990","article-title":"Stem cell factor: a hemopoietic cytokine with important targets in asthma","volume":"2","author":"Oliveira","year":"2003","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.jaci.2020.03.005_bib82","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2133.1997.tb08774.x","article-title":"Eosinophil major basic protein in autologous serum and saline skin tests in chronic idiopathic urticaria","volume":"136","author":"Grattan","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.03.005_bib83","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/bjd.13621","article-title":"Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (\u2018idiopathic') urticaria","volume":"172","author":"Kay","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2020.03.005_bib84","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2340\/0001555572197200","article-title":"Effects of antihistamines on cutaneous reactions and influx of eosinophils after local injection of PAF, kallikrein, compound 48\/80 and histamine in patients with chronic urticaria and healthy subjects","volume":"72","author":"Juhlin","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2020.03.005_bib85","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jaci.2009.11.029","article-title":"Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules","volume":"125","author":"Neves","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000496162","article-title":"Effects of an oral CRTh2 antagonist (AZD1981) on eosinophil activity and symptoms in chronic spontaneous urticaria","volume":"179","author":"Oliver","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib87","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/cea.12348","article-title":"Calcitonin gene-related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria","volume":"44","author":"Kay","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2020.03.005_bib88","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1590\/abd1806-4841.20131532","article-title":"Evaluation of D-dimer serum levels among patients with chronic urticaria, psoriasis and urticarial vasculitis","volume":"88","author":"Criado","year":"2013","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaci.2020.03.005_bib89","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cyto.2010.10.005","article-title":"Induction of IL-13 production and upregulated expression of protease activated receptor-1 by RANTES in a mast cell line","volume":"53","author":"Zhang","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2020.03.005_bib90","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaci.2010.05.047","article-title":"Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab","volume":"126","author":"Magerl","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 3","key":"10.1016\/j.jaci.2020.03.005_bib91","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jdv.13198","article-title":"Management and treatment of chronic urticaria (CU)","volume":"29","author":"Maurer","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2020.03.005_bib92","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/ACI.0000000000000183","article-title":"Mepolizumab-based therapy in asthma: an update","volume":"15","author":"Walsh","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.03.005_bib93","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/ddg.13481","article-title":"Benefit of mepolizumab treatment in a patient with chronic spontaneous urticaria","volume":"16","author":"Magerl","year":"2018","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaci.2020.03.005_bib94","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s40265-017-0740-2","article-title":"Reslizumab in eosinophilic asthma: a review","volume":"77","author":"Deeks","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.jaci.2020.03.005_bib95","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2020.03.005_bib96","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.15720","article-title":"Benefit of benralizumab treatment in a patient with chronic symptomatic dermographism","author":"Bergmann","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2020.03.005_bib97","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pharmthera.2012.06.005","article-title":"Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions","volume":"135","author":"Kiwamoto","year":"2012","journal-title":"Pharmacol Ther"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920304061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920304061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:26:13Z","timestamp":1758792373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920304061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0091674920304061"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.03.005","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of eosinophils in chronic spontaneous urticaria","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}